Statins, cognition, and dementia—systematic review and methodological commentary
about
Pharmacological interventions for cognitive decline in people with Down syndromePharmacological interventions for cognitive decline in people with Down syndromeDifferential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort studyPoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.Developmental and extrahepatic physiological functions of SREBP pathway genes in mice.Statin use and cognitive function in middle-aged adults with type 1 diabetes.A Simulation Platform for Quantifying Survival Bias: An Application to Research on Determinants of Cognitive Decline.Plasma sphingolipids and depressive symptoms in coronary artery disease.The heart-brain connection: from evidence to action.Arterial stiffness, cognitive impairment and dementia: confounding factor or real risk?Effects of Plasma Lipids and Statins on Cognitive Function.Association of midlife lipids with 20-year cognitive change: A cohort study.Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trial.How are we assessing the safety and quality use of medicines used by young people in Australia?
P2860
Q24186316-A5D63E90-B58D-4D9D-BBA2-78E921008B6AQ24188311-8AA22DEA-BB5F-424A-8025-4D711D557A35Q36325378-400AFF5E-3A93-4E08-9E04-171CC2757BFDQ37549374-6B36B792-7B39-4122-AC9B-4F63DD6901D1Q37589656-B870DA1A-22E7-4113-AEE3-DDE3CEA76F9AQ37650830-D56FBD36-9634-40A0-A404-FCF98B0E7FD9Q38653024-7D1253F8-D26E-4600-A2A4-2DD7A219A4F8Q40128220-F3F48139-978C-4F45-B491-E5FC4A8BB217Q40600745-8FD3003C-E03F-4F1F-A699-457A3E2B8CA3Q46248790-87DA6A93-F774-4C5F-849B-E3C41252AE64Q48024308-ABC884E0-D2FF-4F04-81AA-AC4A7E33BE8EQ48027735-B514EDB8-7424-49A9-B590-90E8F720E0E0Q49941044-C036DD5B-34E7-4487-B9C2-E951028A74D6Q50063689-4413275B-3CC2-4E5A-A2CF-715301D2AABCQ50076099-DE50EF11-3DCF-4F4E-ADCA-9A29450722A9Q53302806-87FD54BE-8AA1-444B-BBA7-E6F86AE03769
P2860
Statins, cognition, and dementia—systematic review and methodological commentary
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Statins, cognition, and dementia—systematic review and methodological commentary
@ast
Statins, cognition, and dementia—systematic review and methodological commentary
@en
Statins, cognition, and dementia—systematic review and methodological commentary
@nl
type
label
Statins, cognition, and dementia—systematic review and methodological commentary
@ast
Statins, cognition, and dementia—systematic review and methodological commentary
@en
Statins, cognition, and dementia—systematic review and methodological commentary
@nl
prefLabel
Statins, cognition, and dementia—systematic review and methodological commentary
@ast
Statins, cognition, and dementia—systematic review and methodological commentary
@en
Statins, cognition, and dementia—systematic review and methodological commentary
@nl
P2093
P2860
P356
P1476
Statins, cognition, and dementia—systematic review and methodological commentary
@en
P2093
A. Richey Sharrett
Melinda C. Power
Rebecca F. Gottesman
P2860
P2888
P356
10.1038/NRNEUROL.2015.35
P407
P577
2015-04-01T00:00:00Z
P6179
1019070656